Clinical trial
Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in…
NCT00464204 · Fresenius Kabi, Industry · Completed
Key facts
| NCT number | NCT00464204 |
|---|---|
| Title | Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis |
| Official title | Effects of Voluven on Hemodynamics and Tolerability of Enteral Nutrition in Patients With Severe Sepsis |
| Acronym | CRYSTMAS |
| Lead sponsor | Fresenius Kabi, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Drug |
| Interventions | 6 % Hydroxyethylstarch 130/0.4 = "Voluven®", 0.9 % NaCl |
| Enrollment | 196 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2010 |
| Completion | Dec 1, 2010 |
| First posted | Apr 23, 2007 |
| Last update posted | Jan 11, 2012 |
| Countries | France, Germany |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: